ASSET PURCHASE AGREEMENT by and between CLARUS THERAPEUTICS HOLDINGS, INC., and CLARUS THERAPEUTICS, INC., SELLERS, Tolmar, Inc. PURCHASER, AND TOLMAR HOLDINGS, INC. GUARANTOR DATED AS OF OCTOBER 25, 2022Asset Purchase Agreement • October 31st, 2022 • Clarus Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 31st, 2022 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 25, 2022 (the “Effective Date”), by and between Clarus Therapeutics Holdings, Inc., a Delaware corporation (“Holdings”), Clarus Therapeutics, Inc., a Delaware corporation (“Clarus” and together with Holdings, the “Sellers”), Tolmar, Inc., a Delaware corporation (the “Purchaser”) and Tolmar Holdings, Inc. (as “Guarantor”).